לוסק 20mg
teva pharmaceutical industries ltd, israel - omeprazole - קפסולות - omeprazole 20 mg - omeprazole
אומפרה 40
rafa laboratories ltd - omeprazole - קפסולות - omeprazole 40 mg - omeprazole
סולזול
k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole
אסופרים קונטרול 20 מג
k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - קפסולה קשיחה - esomeprazole as sodium 20 mg - esomeprazole
אזומפרזול מדי מרקט 40 מג
a.l. medi-market ltd. - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole
לוסק 10 מ"ג
abic ltd. - omeprazole 10.0 mg - capsules - omeprazole - - acute duodenal ulcer. - acute gastric ulcer. - helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. - reflux esophagitis:• treatment;• long-term management;• maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. - severe reflux esophagitis in children from one year of age and older • maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer.• zollinger-ellison syndrome.• treatment and prevention of nsaid – associated duodenal and gastric ulcers or erosions in high risk patients.
לוסק 10 מ"ג
abic ltd. - omeprazole 10.0 mg - capsules - omeprazole - - acute duodenal ulcer. - acute gastric ulcer. - helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. - reflux esophagitis:• treatment;• long-term management;• maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. - severe reflux esophagitis in children from one year of age and older • maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer.• zollinger-ellison syndrome.• treatment and prevention of nsaid – associated duodenal and gastric ulcers or erosions in high risk patients.
אומפרה 10
rafa laboratories ltd - omeprazole 10 mg - capsules - omeprazole - acute duodenal ulcer, acute gastric ulcer, helicobacter pylori associated peptic ulcer disease in combination with antibiotics. reflux esophagitis: treatment long-term management, maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. treatment of severe reflux esophagitis in children from one year of age and older. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcer or erosions in high risk patients.
וימובו
astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers.vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.
וימובו
astra zeneca israel ltd - esomeprazole as magnesium trihydrate 20 mg; naproxen 500 mg - tablets modified release - naproxen - vimovo is a combination product that contains naproxen and esomeprazole. it is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing nsaid-associated gastric ulcers. vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.